More info
Active ingredients
Betamethasone + Salicylic Acid
Release form
Ointment
Composition
1 g: Betamethasone dipropionate 640 mcg, which corresponds to the content of betamethasone 500 mcg, salicylic acid 30 mg. Adjuvants: mineral oil, vaseline.
Pharmacological effect
A drug with anti-inflammatory, antipruritic, anti-proliferative, anti-microbial and keratolytic action for external use. Betamethasone has anti-inflammatory, anti-allergic, anti-proliferative and anti-pruritic action. When applied to the skin surface, betamethasone has a quick and strong effect on the inflammation focus, reducing the severity of objective symptoms (erythema, edema, lichenification) and subjective sensations (itching, irritation, pain). Salicylic acid due to keratolytic action clears the lesion areas from scales, promotes the penetration of betamethasone into the skin, supports the acidic environment of the skin, preventing the development of bacterial and fungal infections.
Pharmacokinetics
Data on the pharmacokinetics of the drug Belosalic not provided.
Indications
Subacute and chronic dermatoses, in which therapy with topical corticosteroids is effective, and accompanied by hyperkeratosis and desquamation, including: - psoriasis; - eczema (dishydrotic, seborrheic, tylotic); - neurodermatitis; - lichen planus, - asbestos lichen, - chronic discoid lupus erythematosus - ichthyosis and ichthyosis of the skin; - seborrhea; - seborrheic dermatitis (scalp). The drug in the form of a solution for external use is indicated for use on the scalp, as well as in children 6 months of age and older.
Contraindications
- skin tuberculosis; - skin manifestations of syphilis; - chicken pox; - viral infections of the skin; - skin post-vaccination reactions; - open wounds; - trophic ulcers; - rosacea; - acne vulgaris; - children up to 6 months (for ointment); - hypersensitivity to betamethasone, salicylic acid, or to any of the auxiliary components of the drug.
Precautionary measures
Do not exceed recommended doses.
Use during pregnancy and lactation
The use of the drug Belosalic (in the form of an ointment and / or solution for external use) in pregnant women is allowed in cases where the intended benefit to the mother exceeds the risk to the fetus.In such cases, the use of the drug should be short and limited to small areas of the skin. During breastfeeding, the use of the drug Belosalic is possible under strict indications, but the drug should not be applied to the skin of the mammary gland before feeding.
Dosage and administration
The drug is intended for external use. A small amount of ointment is evenly distributed over the surface of the skin, slightly rubbing. The frequency of use is 2 times / day, in mild cases a single use is sufficient. The duration of a continuous course of treatment is usually limited to 3-4 weeks. If necessary, a longer course of therapy is recommended to use the drug less often, for example, every other day. In the treatment of chronic diseases, treatment should continue for some time after the disappearance of all symptoms, under the supervision of a physician, in order to avoid recurrence of the disease. Repeated courses of therapy are possible within a year.
Side effects
Side effects are usually mild. Dermatological reactions: possible development of hypersensitivity reactions (itching, burning, hyperemia); rarely, acne-like changes, hypopigmentation, striae, skin atrophy, hypertrichosis, telangiectasia, secondary infections of the skin. With prolonged continuous use and large areas of the skin, betamethasone can cause systemic side reactions associated with suppression of the function of the adrenal cortex. the drug should be withdrawn.
Overdose
With long-term continuous use of a combination of betamethasone and salicylic acid, especially in children, on vast skin surfaces, when applied to the skin with impaired integrity or when used under an occlusive dressing, enhanced absorption of active ingredients and manifestation of systemic effects (secondary adrenal insufficiency, hypercorticism, Itsenko-Cushing syndrome). Treatment: recommended drug withdrawal and symptomatic therapy.
Interaction with other drugs
There are no clinically significant interactions with other drugs. The simultaneous use of cosmetic and dermatological agents for the treatment of acne, products containing ethanol, or medical soap with a pronounced drying effect can, in certain cases, cause skin irritation.
special instructions
The ointment is intended only for external use on the skin and / or scalp. Avoid contact with the eyes and mucous membranes. Long-term use of the ointment on the skin of the face is not recommended due to the possible development of dermatitis like rosacea, perioral dermatitis, skin atrophy and Acne. Avoid using the drug in the anogenital area. It is not recommended to use the drug under an occlusive dressing, unless necessary. With the development of fungal or bacterial microflora on the skin, additional use of an antibacterial or antifungal agent is necessary. Use in pediatrics Use of Belosalic in children should be as short as possible while following strict precautions, since in children, there is a danger of systemic absorption in proportion to a larger number of active components due to the predominance of skin area over body weight and insufficient maturity of the epidermis. The drug should not be used in children under bandages and, especially under plasticized diapers, which may increase the risk of undesirable effects. Effect on the ability to drive vehicles and control mechanisms The adverse effects of the drug Belosalic on the ability to drive vehicles and mechanisms are not available.